Comments on the 2023 ESC guidelines on cardiovascular disease in patients with diabetes

The new guidelines of the European Society of Cardiology (ESC) 2023 for the management of patients with cardiovascular (CV) disease (CVD) and diabetes incorporate a central figure that focuses on the presentation of a patient with diabetes and CVD: first case: a patient with CVD that includes athero...

Descripción completa

Detalles Bibliográficos
Autores: Campuzano, Raquel, Mazón, Pilar, Castro Conde, Almudena, Cid Álvarez, Ana Belén, Cruzado Álvarez, Concepción, Díez Villanueva, Pablo, Fernández Olmo, Rosa, Freixa Pamias, Román, Marzal Martin, Domingo, Mirabet Pérez, Sonia, Ferreiro, José Luis, Avanzas, Pablo, Andrea, Rut, Boraita, Araceli, Calvo, David, Campuzano Ruiz, Raquel, Delgado, Victoria, Dos Subirá, Laura, Gómez-Doblas, Juan José, Martínez Momblán, Ma. Antonia, Pascual Figa, Domingo, Sanchis, Juan, De la Torre Hernández, José María, Vivas, David
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2024
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/225582
Acceso en línea:https://hdl.handle.net/2445/225582
Access Level:acceso abierto
Palabra clave:Cardiologia
Diabetis
Malalties cardiovasculars
Cardiology
Diabetes
Cardiovascular diseases
id ES_d5b70a09718b292ac26d8dae1a4e4834
oai_identifier_str oai:diposit.ub.edu:2445/225582
network_acronym_str ES
network_name_str España
repository_id_str
spelling Comments on the 2023 ESC guidelines on cardiovascular disease in patients with diabetesCampuzano, RaquelMazón, PilarCastro Conde, AlmudenaCid Álvarez, Ana BelénCruzado Álvarez, ConcepciónDíez Villanueva, PabloFernández Olmo, RosaFreixa Pamias, RománMarzal Martin, DomingoMirabet Pérez, SoniaFerreiro, José LuisAvanzas, PabloAndrea, RutBoraita, AraceliCalvo, DavidCampuzano Ruiz, RaquelDelgado, VictoriaDos Subirá, LauraGómez-Doblas, Juan JoséMartínez Momblán, Ma. AntoniaMazón, PilarPascual Figa, DomingoSanchis, JuanDe la Torre Hernández, José MaríaVivas, DavidCardiologiaDiabetisMalalties cardiovascularsCardiologyDiabetesCardiovascular diseasesThe new guidelines of the European Society of Cardiology (ESC) 2023 for the management of patients with cardiovascular (CV) disease (CVD) and diabetes incorporate a central figure that focuses on the presentation of a patient with diabetes and CVD: first case: a patient with CVD that includes atherosclerotic cardiovascular disease (ASCVD), atrial fibrillation (AF) and heart failure (HF), in whom diabetes screening must be performed; second case, a patient with diabetes in whom CVD or chronic kidney disease (CKD) must be ruled out. In the first case, there are no changes for the diagnosis of diabetes using the already known diagnostic criteria1: a) fasting plasma glucose ≥ 126mg/dL; b) glycated hemoglobin (HbA1c) ≥ 6.5%; c) plasma glucose 2hours after an oral glucose overload test (75g) ≥ 200mg/dL; and d) plasma glucose ≥ 200mg/dL in patients with classic symptoms of hyperglycemia or a hyperglycemic crisis. In the second case, CVD screening is recommended based on the patient's symptoms and electrocardiogram (ECG). The document does not introduce peptides in this screening, or imaging tests, or detection of ischemia in asymptomatic patients with diabetes.Elsevier España2024info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersionapplication/pdfhttps://hdl.handle.net/2445/225582Articles publicats en revistes (Infermeria Fonamental i Clínica)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésVersió postprint del document publicat a: https://doi.org/10.1016/j.rec.2023.11.005Revista Española de Cardiología (English Edition), 2024, vol. 77, num.3, p. 196-200https://doi.org/10.1016/j.rec.2023.11.005cc-by-nc-nd (c) Sociedad Española de Cardiología, 2024http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/2255822026-05-27T06:46:51Z
dc.title.none.fl_str_mv Comments on the 2023 ESC guidelines on cardiovascular disease in patients with diabetes
title Comments on the 2023 ESC guidelines on cardiovascular disease in patients with diabetes
spellingShingle Comments on the 2023 ESC guidelines on cardiovascular disease in patients with diabetes
Campuzano, Raquel
Cardiologia
Diabetis
Malalties cardiovasculars
Cardiology
Diabetes
Cardiovascular diseases
title_short Comments on the 2023 ESC guidelines on cardiovascular disease in patients with diabetes
title_full Comments on the 2023 ESC guidelines on cardiovascular disease in patients with diabetes
title_fullStr Comments on the 2023 ESC guidelines on cardiovascular disease in patients with diabetes
title_full_unstemmed Comments on the 2023 ESC guidelines on cardiovascular disease in patients with diabetes
title_sort Comments on the 2023 ESC guidelines on cardiovascular disease in patients with diabetes
dc.creator.none.fl_str_mv Campuzano, Raquel
Mazón, Pilar
Castro Conde, Almudena
Cid Álvarez, Ana Belén
Cruzado Álvarez, Concepción
Díez Villanueva, Pablo
Fernández Olmo, Rosa
Freixa Pamias, Román
Marzal Martin, Domingo
Mirabet Pérez, Sonia
Ferreiro, José Luis
Avanzas, Pablo
Andrea, Rut
Boraita, Araceli
Calvo, David
Campuzano Ruiz, Raquel
Delgado, Victoria
Dos Subirá, Laura
Gómez-Doblas, Juan José
Martínez Momblán, Ma. Antonia
Mazón, Pilar
Pascual Figa, Domingo
Sanchis, Juan
De la Torre Hernández, José María
Vivas, David
author Campuzano, Raquel
author_facet Campuzano, Raquel
Mazón, Pilar
Castro Conde, Almudena
Cid Álvarez, Ana Belén
Cruzado Álvarez, Concepción
Díez Villanueva, Pablo
Fernández Olmo, Rosa
Freixa Pamias, Román
Marzal Martin, Domingo
Mirabet Pérez, Sonia
Ferreiro, José Luis
Avanzas, Pablo
Andrea, Rut
Boraita, Araceli
Calvo, David
Campuzano Ruiz, Raquel
Delgado, Victoria
Dos Subirá, Laura
Gómez-Doblas, Juan José
Martínez Momblán, Ma. Antonia
Pascual Figa, Domingo
Sanchis, Juan
De la Torre Hernández, José María
Vivas, David
author_role author
author2 Mazón, Pilar
Castro Conde, Almudena
Cid Álvarez, Ana Belén
Cruzado Álvarez, Concepción
Díez Villanueva, Pablo
Fernández Olmo, Rosa
Freixa Pamias, Román
Marzal Martin, Domingo
Mirabet Pérez, Sonia
Ferreiro, José Luis
Avanzas, Pablo
Andrea, Rut
Boraita, Araceli
Calvo, David
Campuzano Ruiz, Raquel
Delgado, Victoria
Dos Subirá, Laura
Gómez-Doblas, Juan José
Martínez Momblán, Ma. Antonia
Pascual Figa, Domingo
Sanchis, Juan
De la Torre Hernández, José María
Vivas, David
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Cardiologia
Diabetis
Malalties cardiovasculars
Cardiology
Diabetes
Cardiovascular diseases
topic Cardiologia
Diabetis
Malalties cardiovasculars
Cardiology
Diabetes
Cardiovascular diseases
description The new guidelines of the European Society of Cardiology (ESC) 2023 for the management of patients with cardiovascular (CV) disease (CVD) and diabetes incorporate a central figure that focuses on the presentation of a patient with diabetes and CVD: first case: a patient with CVD that includes atherosclerotic cardiovascular disease (ASCVD), atrial fibrillation (AF) and heart failure (HF), in whom diabetes screening must be performed; second case, a patient with diabetes in whom CVD or chronic kidney disease (CKD) must be ruled out. In the first case, there are no changes for the diagnosis of diabetes using the already known diagnostic criteria1: a) fasting plasma glucose ≥ 126mg/dL; b) glycated hemoglobin (HbA1c) ≥ 6.5%; c) plasma glucose 2hours after an oral glucose overload test (75g) ≥ 200mg/dL; and d) plasma glucose ≥ 200mg/dL in patients with classic symptoms of hyperglycemia or a hyperglycemic crisis. In the second case, CVD screening is recommended based on the patient's symptoms and electrocardiogram (ECG). The document does not introduce peptides in this screening, or imaging tests, or detection of ischemia in asymptomatic patients with diabetes.
publishDate 2024
dc.date.none.fl_str_mv 2024
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
format article
status_str acceptedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/225582
url https://hdl.handle.net/2445/225582
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Versió postprint del document publicat a: https://doi.org/10.1016/j.rec.2023.11.005
Revista Española de Cardiología (English Edition), 2024, vol. 77, num.3, p. 196-200
https://doi.org/10.1016/j.rec.2023.11.005
dc.rights.none.fl_str_mv cc-by-nc-nd (c) Sociedad Española de Cardiología, 2024
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc-by-nc-nd (c) Sociedad Española de Cardiología, 2024
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier España
publisher.none.fl_str_mv Elsevier España
dc.source.none.fl_str_mv Articles publicats en revistes (Infermeria Fonamental i Clínica)
reponame:Dipòsit Digital de la UB
instname:Universidad de Barcelona
instname_str Universidad de Barcelona
reponame_str Dipòsit Digital de la UB
collection Dipòsit Digital de la UB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869420750119632896
score 15,812429